Suppr超能文献

德国 A 型急性主动脉夹层登记处:结构、结果及未来展望。

German Registry for Acute Aortic Dissection Type A: Structure, Results, and Future Perspectives.

作者信息

Boening A, Karck M, Conzelmann L O, Easo J, Krüger T, Rylski B, Weigang E

机构信息

Department of Cardiovascular Surgery, University Hospital Giessen, Giessen, Germany.

Department of Cardiac Surgery, Heidelberg University, Heidelberg, Germany.

出版信息

Thorac Cardiovasc Surg. 2017 Mar;65(2):77-84. doi: 10.1055/s-0036-1572436. Epub 2016 Mar 14.

Abstract

The German Registry for Acute Aortic Dissection Type A (GERAADA) as an international registry for acute aortic dissection type A (AADA) offers a unique opportunity to answer questions regarding acute dissections that cannot be answered by single institution's database alone. GERAADA was started in 2006 by the German Society for Thoracic and Cardiovascular Surgery (GSTCVS) and has collected more than 3,300 AADA patients' data from 56 centers in Germany, Austria, and Switzerland up to now. In the second generated validated dataset comprising the years from 2006 to 2010, 2,137 patients were surgically treated for AADA with an overall 30-day mortality of 16.9%, and a new postoperative neurologic dysfunction of 9.5%. Risk factors for neurologic dysfunction were malperfusion syndromes, dissections of the supra-aortic vessels, and longer operating time. Neuroprotective drugs had no influence on stroke rates. Hypothermic circulatory arrest and antegrade selective cerebral perfusion (ACP) led to similar results if arrest times were less than 30 minutes while ACP for longer arrest periods is advisable. Septuagenarians had an early mortality rate (15.8%) similar to the whole cohort's, but the mortality rate in octogenarians (34.9%) was much higher. GERAADA with its validated 2,137 patient files (2006-2010) is the largest database on AADA worldwide and continues to collect data. Structured follow-up of more than 5 years will be available in the future.

摘要

德国A型急性主动脉夹层注册研究(GERAADA)作为一项关于A型急性主动脉夹层(AADA)的国际注册研究,提供了一个独特的机会来回答有关急性夹层的问题,而这些问题仅靠单一机构的数据库是无法解答的。GERAADA由德国胸心血管外科学会(GSTCVS)于2006年启动,截至目前已收集了来自德国、奥地利和瑞士56个中心的3300多名AADA患者的数据。在包含2006年至2010年的第二代验证数据集中,2137例患者接受了AADA手术治疗,30天总死亡率为16.9%,新出现的术后神经功能障碍发生率为9.5%。神经功能障碍的危险因素包括灌注不良综合征、主动脉弓上血管夹层和手术时间较长。神经保护药物对卒中发生率没有影响。如果停循环时间少于30分钟,低温停循环和顺行性选择性脑灌注(ACP)会产生相似的结果,而对于更长的停循环时间,建议采用ACP。70多岁患者的早期死亡率(15.8%)与整个队列相似,但80多岁患者的死亡率(34.9%)要高得多。拥有经过验证的2137份患者档案(2006 - 2010年)的GERAADA是全球最大的AADA数据库,并且仍在继续收集数据。未来将提供超过5年的结构化随访数据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验